APA (7th ed.) Citation

Tang, W., Zhou, J., Zhao, W., Lin, F., Xue, L., & Guo, Y. (2026). Molecular Subtype-Associated Response to Cyclophosphamide–Epirubicin–Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective Single-Center Study. Cancers, 18(11), 1847. https://doi.org/10.3390/cancers18111847

Chicago Style (17th ed.) Citation

Tang, Wenbo, Jiuli Zhou, Wei Zhao, Fengjuan Lin, Liqiong Xue, and Ye Guo. "Molecular Subtype-Associated Response to Cyclophosphamide–Epirubicin–Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective Single-Center Study." Cancers 18, no. 11 (2026): 1847. https://doi.org/10.3390/cancers18111847.

MLA (9th ed.) Citation

Tang, Wenbo, et al. "Molecular Subtype-Associated Response to Cyclophosphamide–Epirubicin–Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective Single-Center Study." Cancers, vol. 18, no. 11, 2026, p. 1847, https://doi.org/10.3390/cancers18111847.